NCT02763150 is a NA clinical trial of Lifestyle intervention in Gestational Diabetes Mellitus, sponsored by California Polytechnic State University-San Luis Obispo.

Who is sponsoring NCT02763150?

NCT02763150 is sponsored by California Polytechnic State University-San Luis Obispo.

What drugs are being tested in NCT02763150?

Interventions in NCT02763150: Lifestyle intervention, Health Promotion.

What condition does NCT02763150 study?

NCT02763150 studies Gestational Diabetes Mellitus.

Is NCT02763150 still recruiting?

NCT02763150 is currently completed. Last updated 2 August 2022.

Last reviewed 2022-08-02 · How we verify

NCT02763150

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pre-pregnancy Lifestyle Intervention to Prevent the Recurrence of Gestational Diabetes in Overweight and Obese Women

Completed NA Last updated 2 August 2022

What this trial tests

NA trial testing Lifestyle intervention in Gestational Diabetes Mellitus in 199 participants. Completed in 29 July 2022.

Timeline

15 December 2017

Primary endpoint
15 April 2022

29 July 2022

Quick facts

Lead sponsor	California Polytechnic State University-San Luis Obispo
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	199
Start date	15 December 2017
Primary completion	15 April 2022
Estimated completion	29 July 2022
Sites	2 locations across United States

Drugs / interventions tested

Lifestyle intervention
Health Promotion

Conditions studied

Gestational Diabetes Mellitus — all drugs for Gestational Diabetes Mellitus →

Sponsor

California Polytechnic State University-San Luis Obispo

Who can join

18 and older, female only, with Gestational Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overall purpose of this study is to determine the efficacy of a pre-pregnancy lifestyle intervention to reduce the recurrence of gestational diabetes mellitus in multiethnic women with overweight or obesity.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Protocol for a randomized controlled trial of pre-pregnancy lifestyle intervention to reduce recurrence of gestational diabetes: Gestational Diabetes Prevention/Prevención de la Diabetes Gestacional.
Phelan S, Jelalian E, Coustan D, Caughey AB, et al · · 2021 · cited 21× · PMID 33827659 · DOI 10.1186/s13063-021-05204-w
Rationale and study design for lifestyle intervention in preparation for pregnancy (LIPP): A randomized controlled trial.
Erickson ML, Mey JT, Axelrod CL, Paul D, et al · · 2020 · cited 12× · PMID 32389808 · DOI 10.1016/j.cct.2020.106024
Protocol for a randomized controlled trial of pre-pregnancy lifestyle intervention to reduce recurrence of gestational diabetes: Gestational Diabetes Prevention/Prevención de la Diabetes Gestacional
Phelan S, Jelalian E, Coustan D, Castorino K, et al · · 2021 · DOI 10.21203/rs.3.rs-297367/v1

Verify or expand the search:

Other trials of Lifestyle intervention

Trials testing the same drug.

NCT07163546 — Person-Centered Lifestyle Redesign in Chronic Low Back Pain · NA · enrolling by invitation
NCT06903923 — Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy · Phase 2 · recruiting
NCT06395558 — intErnet-based iNterventions FOR Cardiac arrEst suRvivors · NA · recruiting
NCT06441409 — Effect of Lifestyle Intervention on Mobilization of Fat Storage and Iron Deposition in Obesity · NA · completed
NCT05850182 — Lifestyle Intervention in Patients With Metastatic Prostate Cancer · NA · recruiting

Other recruiting trials for Gestational Diabetes Mellitus

Currently open trials in the same condition.

NCT06997835 — The Role of Early Nursing Intervention in the High-risk Population of Gestational Diabetes · NA · active not recruiting
NCT06648174 — The Project for Managing Cardiometabolic Risk in Women Diagnosed With Gestational Diabetes Mellitus · NA · recruiting
NCT06436326 — The Impact of Continuous Glucose Monitoring on Maternal and Infant's Outcomes in Gestational Diabetes · NA · recruiting
NCT05852054 — Supporting Transitions to Primary Care Among Under-resourced, Postpartum Women (STEP-UP) · Phase 3 · active not recruiting
NCT05800509 — Gestational Diabetes and Perinatal Depression: an Intervention Program · NA · recruiting

Other California Polytechnic State University-San Luis Obispo trials

Trials by the same sponsor.

NCT06988306 — Lifestyle Interventions to Prevent Diabetes in U.S. Home Visiting Programs · NA · recruiting
NCT05750407 — Feasibility of Cardiovascular Health Intervention Within Evidence-based Home Visiting · NA · completed
NCT05780944 — Short-term Effects of Paced Bottle-Feeding on Feeding Interactions · NA · completed
NCT05781100 — Investigating Baby Behavior and Family Technology Use Study · NA · recruiting
NCT03929575 — Effects of Herbal Supplements on Endurance Exercise Performance · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02763150 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by California Polytechnic State University-San Luis Obispo
Last refreshed: 2 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02763150.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing